ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.8B
Enterprise Value 32.57B
Trailing P/E N/A
Forward P/E 1-15.10
PEG Ratio (5 yr expected) 1-0.57
Price/Sales (ttm)2,027.89
Price/Book (mrq)6.91
Enterprise Value/Revenue 31,860.18
Enterprise Value/EBITDA 6-18.03

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-10,383.98%

Management Effectiveness

Return on Assets (ttm)-28.64%
Return on Equity (ttm)-55.80%

Income Statement

Revenue (ttm)1.38M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-92.50%
Gross Profit (ttm)1.53M
EBITDA -142.58M
Net Income Avi to Common (ttm)-163.25M
Diluted EPS (ttm)-4.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)405.89M
Total Cash Per Share (mrq)9.77
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)20.55
Book Value Per Share (mrq)9.75

Cash Flow Statement

Operating Cash Flow (ttm)-128.83M
Levered Free Cash Flow (ttm)-81.12M

Trading Information

Stock Price History

Beta 1.00
52-Week Change 3148.69%
S&P500 52-Week Change 314.44%
52 Week High 376.29
52 Week Low 326.30
50-Day Moving Average 368.09
200-Day Moving Average 364.46

Share Statistics

Avg Vol (3 month) 3132.25k
Avg Vol (10 day) 3118.72k
Shares Outstanding 541.6M
Float 22.57M
% Held by Insiders 124.80%
% Held by Institutions 144.69%
Shares Short (Jun 15, 2018) 4249.74k
Short Ratio (Jun 15, 2018) 41.98
Short % of Float (Jun 15, 2018) 4N/A
Short % of Shares Outstanding (Jun 15, 2018) 40.60%
Shares Short (prior month May 15, 2018) 4233.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A